IRIS
CONTI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.430
AS - Asia 9.213
EU - Europa 6.940
SA - Sud America 1.554
AF - Africa 529
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 28.688
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.085
SG - Singapore 3.466
CN - Cina 2.593
VN - Vietnam 1.560
BR - Brasile 1.224
DE - Germania 1.082
IE - Irlanda 1.082
FI - Finlandia 874
UA - Ucraina 862
IT - Italia 837
SE - Svezia 832
HK - Hong Kong 601
ZA - Sudafrica 382
FR - Francia 335
NL - Olanda 314
CA - Canada 247
TR - Turchia 211
BD - Bangladesh 174
GB - Regno Unito 174
AT - Austria 173
RU - Federazione Russa 137
AR - Argentina 128
IN - India 120
JP - Giappone 73
EC - Ecuador 66
MX - Messico 59
IQ - Iraq 54
ES - Italia 49
ID - Indonesia 47
BE - Belgio 45
KR - Corea 35
PK - Pakistan 34
PL - Polonia 34
PH - Filippine 33
CO - Colombia 32
MA - Marocco 32
VE - Venezuela 30
TW - Taiwan 27
KE - Kenya 26
PY - Paraguay 26
UZ - Uzbekistan 26
EG - Egitto 23
CZ - Repubblica Ceca 22
TH - Thailandia 22
LT - Lituania 19
SA - Arabia Saudita 17
IL - Israele 16
UY - Uruguay 15
JO - Giordania 14
NP - Nepal 13
CL - Cile 12
EU - Europa 12
TN - Tunisia 12
AZ - Azerbaigian 11
CI - Costa d'Avorio 11
AE - Emirati Arabi Uniti 10
BO - Bolivia 9
CR - Costa Rica 9
PE - Perù 9
BG - Bulgaria 7
CH - Svizzera 7
RO - Romania 7
ET - Etiopia 6
JM - Giamaica 6
KZ - Kazakistan 6
OM - Oman 6
PS - Palestinian Territory 6
RS - Serbia 6
BH - Bahrain 5
BJ - Benin 5
BY - Bielorussia 5
LB - Libano 5
AO - Angola 4
AU - Australia 4
DO - Repubblica Dominicana 4
MY - Malesia 4
PA - Panama 4
PT - Portogallo 4
TG - Togo 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CY - Cipro 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
KW - Kuwait 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TT - Trinidad e Tobago 3
ZW - Zimbabwe 3
AM - Armenia 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GY - Guiana 2
HR - Croazia 2
Totale 28.639
Salva come PNG Salva come JPEG
Città #
Singapore 1.543
Ashburn 1.072
Dublin 1.070
Jacksonville 968
San Jose 926
Chandler 885
Beijing 645
Hong Kong 577
Dallas 572
Santa Clara 547
Ho Chi Minh City 501
Dearborn 403
Boardman 362
Johannesburg 357
Hanoi 354
Nanjing 339
Ann Arbor 332
Bremen 260
Princeton 259
San Mateo 248
Lauterbourg 229
Parma 220
Munich 206
New York 190
Los Angeles 173
Vienna 163
Toronto 161
Helsinki 153
Izmir 149
Wilmington 136
Shanghai 124
Des Moines 119
Shenyang 114
Hefei 112
Moscow 97
São Paulo 96
Kunming 95
Hebei 93
Nanchang 87
Council Bluffs 79
Haiphong 75
Buffalo 74
Jinan 69
Da Nang 62
Woodbridge 59
Seattle 57
Marseille 54
Columbus 51
Grafing 51
Turku 51
Milan 50
Guangzhou 49
Changsha 47
Tianjin 46
Düsseldorf 45
Tokyo 44
Brussels 43
Houston 35
Jiaxing 35
Rio de Janeiro 35
The Dalles 35
Fortaleza 34
Orem 33
Brooklyn 31
Montreal 31
Frankfurt am Main 29
Hải Dương 29
Biên Hòa 28
Fremont 28
Warsaw 28
Atlanta 27
Chennai 27
Denver 27
Quito 27
Seoul 25
Zhengzhou 25
Norwalk 24
Hangzhou 23
London 23
Nuremberg 23
Rome 23
Jakarta 22
Tashkent 22
Brasília 21
Bắc Ninh 20
Nairobi 20
Porto Alegre 20
Can Tho 19
Curitiba 19
Phoenix 19
San Francisco 19
Verona 19
Belo Horizonte 18
Amsterdam 17
Istanbul 17
Salvador 17
Baghdad 16
Boston 16
Chicago 16
Buenos Aires 15
Totale 16.980
Salva come PNG Salva come JPEG
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 283
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 247
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 226
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 221
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 215
Anti-Staphylococcus aureus Activity and Structural Characterization of Rationally Designed Peptides 205
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 203
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 201
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 198
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 193
Antibodies as a source of anti-infective peptides: an update 191
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 189
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 189
A synthetic peptide as a novel anticryptococcal agent 184
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 183
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 182
Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study 178
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 176
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 176
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 176
Activity of Synthetic Peptide KP and Its Derivatives against Biofilm-Producing Escherichia coli Strains Resistant to Cephalosporins 174
Metabolic profiling of Candida albicans 173
Antifungal peptides within the antibodies 171
Fungicidal activity of peptides encoded by immunoglobulin genes 167
Antimicrobial effect on candida albicans biofilm bapplication of different wavelengths and dyes and the synthetic killer decapeptide KP 166
Antifungal activity of the C-terminal peptide from human serum albumin 165
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 165
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 165
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 164
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 163
L’antibiogramma per i miceti 162
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 160
Anaerobic yeast killer system. 155
Antibody peptide based antifungal immunotherapy 155
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 154
Peptides from the inside of the antibodies are active against infectious agents and tumours 154
Novel Arginine- and Proline-Rich Candidacidal Peptides Obtained through a Bioinformatic Approach 153
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BIOFILMS WITH DIFFERENT WAVELENGTHS AND DYES WITH SYNTHETIC KILLER DECAPEPTIDE 153
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 152
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 151
Anticorpi immagini interne di tossine killer 150
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 150
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 150
Natural and synthetic peptides with antifungal activity 150
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 149
Antimicrobial photodynamic therapy protocols on streptococcus mutans with different combinations of wavelengths and photosensitizing dyes 149
Antibody-mediated protective immunity in fungal infections 149
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 149
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 148
Antibiobodies: antibiotic-like antiidiotypic antibodies. 145
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 142
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 141
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 141
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 141
Valutazione del sistema Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 per il rilevamento di micobatteri dai materiali patologici in comparazione ai metodi radiometrico e tradizionale 140
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 139
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 139
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 138
Mode of action of a killer peptide against Toxoplasma gondii 138
Antireceptor yeast killer toxin-like antibiobodies 137
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 137
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 137
Antibiobodies: antibiotic internal image antibodies 136
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 136
Detection of Mycobacterium bovis in bovine tissue samples by the Abbott LCx Mycobacterium tuberculosis assay and comparison with culture methods 135
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 135
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 135
A Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species 134
Guideline for the analysis of the microbial communities of the human upper airways 133
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 133
Metabolic profile of Candida albicans 132
Wickerhamomyces yeast killer toxins’ medical applications 132
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 132
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 131
Allergic bronchopulmonary aspergillosis: An important cause of asthma which is sometimes ignored 130
Antibiotic antibodies 127
In vitro and in vivo anticandidal activity of killer peptide derivatives 126
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 124
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 123
Innate antimicrobial and antiviral activities of antibody peptides 123
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 123
The Variability of the Salivary Antimicrobial Peptide Profile: Impact of Lifestyle 122
Restriction of Influenza virus multiplication induced by PK peptide treatment 121
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 121
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 120
Marcatori epidemiologici. 118
A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi 118
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 116
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 113
Antibodies as Crypts of Antiinfective and Antitumor Peptides 112
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 112
Any antibody fragment might exert antifungal activity 112
Candidacidal properties of peptides encoded by immunoglobulin genes 112
Yeast killer toxins and dimorphism. 110
Immagine interna del fenomeno killer dei lieviti 109
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 108
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 108
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 108
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 108
Human natural yeast killer toxin-like antibodies 107
Totale 15.032
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/20221.306 31 6 24 59 58 68 169 221 51 128 64 427
2022/20234.045 504 352 216 259 539 456 35 235 1.311 12 92 34
2023/20241.363 79 147 48 55 132 381 59 77 25 90 113 157
2024/20254.772 52 303 317 334 357 517 149 197 788 485 382 891
2025/202610.682 840 1.049 1.356 1.231 1.469 600 1.218 410 1.357 691 303 158
Totale 28.895